About Carmenta Bio
Carmenta Bio is a company based in Palo Alto (United States) founded in 2012 was acquired by Progenity in April 2015. Carmenta Bio has raised $2.59 million across 2 funding rounds from investors including Progenity. Carmenta Bio operates in a competitive market with competitors including Celmatix, Metabolomic Diagnostics, adyn, LIA Diagnostics and Confer Health, among others.
- Headquarter Palo Alto, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Carmenta Bioscience Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Carmenta Bio
Carmenta Bio has successfully raised a total of $2.59M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2 million completed in August 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Carmenta Bio
Carmenta Bio has secured backing from 1 investor. Prominent investors backing the company include Progenity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
Locked | Locked | Locked |
Investor details for Carmenta Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Carmenta Bio
Investment portfolio details for Carmenta Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Carmenta Bio
Detailed financials for Carmenta Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Carmenta Bio Comparisons
Peer comparison for Carmenta Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Carmenta Bio
Carmenta Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, Metabolomic Diagnostics, adyn, LIA Diagnostics and Confer Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fertility decisions are optimized using data analytics and genomics.
|
|
| Locked | Locked | Locked |
Diagnostics and prognostics for maternal health are developed using metabolomics.
|
|
| Locked | Locked | Locked |
Provider of DNA and hormone analysis based birth control optimization kits
|
|
| Locked | Locked | Locked |
Disposable paper pregnancy test kits
|
|
| Locked | Locked | Locked |
Clinical-grade diagnostic tests for home use are developed.
|
|
| Locked | Locked | Locked |
Exosome-based diagnostic products for health screening are offered.
|
Detailed competitors of Carmenta Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Carmenta Bio
Complete news archive for Carmenta Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Carmenta Bio
Carmenta Bio was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Carmenta Bio is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Carmenta Bio is a funded company, having raised a total of $2.59M across 2 funding rounds to date.
Carmenta Bio was founded in 2012 in Palo Alto, United States, as a Stanford spin-out focused on biotechnology for womens health. Proprietary computational algorithms were combined with protein sera measurements in its platform to enable maternal diagnostics. A diagnostic test for preeclampsia was offered for both symptomatic and asymptomatic expectant mothers. The company was acquired by Progenity in April 2015.
Carmenta Bio's top competitors include Celmatix, Metabolomic Diagnostics and LIA Diagnostics.
Carmenta Bio has 1 investor. Key investors include Progenity.